The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Pain-Induced Negative Affect Is Mediated via Recruitment of The Nucleus Accumbens Kappa Opioid System
Open accessAbstract
Negative affective states affect quality of life for patients suffering from pain. These maladaptive emotional states can lead to involuntary opioid overdose and many neuropsychiatric comorbidities. Uncovering the mechanisms responsible for pain-induced negative affect is critical in addressing these comorbid outcomes. The nucleus accumbens (NAc) shell, which integrates the aversive and rewarding valence of stimuli, exhibits plastic adaptations in the presence of pain. In discrete regions of the NAc, activation of the kappa opioid receptor (KOR) decreases the reinforcing properties of rewards and induces aversive behaviors. Using complementary techniques, we report that in vivo recruitment of NAc shell dynorphin neurons, acting through KOR, is necessary and sufficient to drive pain-induced negative affect. Taken together, our results provide evidence that pain-induced adaptations in the kappa opioid system within the NAc shell represent a functional target for therapeutic intervention that could circumvent pain-induced affective disorders. VIDEO ABSTRACT.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The dynorphin/k-opioid receptor system may also be engaged in negative emotional states that are associated with chronic pain (Cahill et al., 2014;Massaly et al., 2016Massaly et al., , 2019)).”
From Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development (2021) · cites this paper as Massaly et al., 2019
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The local infusion of microgram amounts of the k-opioid receptor antagonist nor-BNI into the ventral NAc shell blocked conditioned place aversion and the lower motivation to self-administer sucrose that was produced by inflammation (Massaly et al., 2019).”
From Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development (2021) · cites this paper as Massaly et al., 2019
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Indeed, in a study of chronic inflammatory pain that was induced by a hindpaw injection of Complete Freund's Adjuvant, dynorphin expression increased in dynorphin-containing neurons in a discrete subregion of the NAc shell through a disinhibition mechanism, and pain increased k-opioid receptor function (Massaly et al., 2019).”
From Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development (2021) · cites this paper as Massaly et al., 2019
The cited source says what the claim attributes to it.
In the citing paper
“Even more compelling, using a series of pharmacological, optogenetic, and chemogenetic approaches, the authors showed that both dynorphin-containing neurons and k-opioid receptor activity in the NAc shell were necessary and sufficient to drive pain-induced negative affective states (Massaly et al., 2019).”
From Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development (2021) · cites this paper as Massaly et al., 2019
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neurons containing hypocretin (orexin) project to multiple neuronal systems
Peyron, C., Tighe, D. K., van den Pol, A. N., de Lecea, L., Heller, H. C., Sutcliffe, J. G., & Kilduff, T. S. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-23-09996.1998 · Cited by 3,466
(2012) · doi:10.1016/j.jmoldx.2011.08.002 · Cited by 2,567
The mesolimbic dopamine reward circuit in depression
Nestler, E. J., & Carlezon, W. A. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.09.018 · Cited by 2,059
Roth, B. L. (2016) · Neuron · doi:10.1016/j.neuron.2016.01.040 · Cited by 1,742
Opioid Abuse in Chronic Pain — Misconceptions and Mitigation Strategies
Volkow, N. D., & McLellan, A. T. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1507771 · Cited by 1,366
A Randomized Trial of Focused Ultrasound Thalamotomy for Essential Tremor
Elias, W. J., Lipsman, N., Ondo, W. G., Ghanouni, P., Kim, Y. G., Lee, W., Schwartz, M., Hynynen, K., Lozano, A. M., Shah, B. B., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1600159 · Cited by 1,167
CRH Engagement of the Locus Coeruleus Noradrenergic System Mediates Stress-Induced Anxiety
McCall, J. G., Al-Hasani, R., Siuda, E. R., Hong, D. Y., Norris, A. J., Ford, C. P., & Bruchas, M. R. (2015) · Neuron · doi:10.1016/j.neuron.2015.07.002 · Cited by 666
Self-citationAn excitatory paraventricular nucleus to AgRP neuron circuit that drives hunger
Krashes, M. J., Shah, B. P., Madara, J. C., Olson, D. P., Strochlic, D. E., Garfield, A. S., Vong, L., Pei, H., Watabe-Uchida, M., Uchida, N., et al. (2014) · Nature · doi:10.1038/nature12956 · Cited by 603
The Dysphoric Component of Stress Is Encoded by Activation of the Dynorphin κ-Opioid System
Land, B. B., Bruchas, M. R., Lemos, J. C., Xu, M., Melief, E. J., & Chavkin, C. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4458-07.2008 · Cited by 601
Self-citationThe dynorphin/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors
Bruchas, M. R., Land, B. B., & Chavkin, C. (2010) · Brain Research · doi:10.1016/j.brainres.2009.08.062 · Cited by 544
Self-citationChronic pain patients are impaired on an emotional decision-making task
Apkarian, V. A., Sosa, Y., Krauss, B. R., Thomas, S. P., Fredrickson, B. E., Levy, R. E., Harden, N. R., & Chialvo, D. R. (2004) · Pain · doi:10.1016/j.pain.2003.12.015 · Cited by 536
Dynorphin, stress, and depression
Knoll, A. T., & Carlezon, W. A. (2010) · Brain Research · doi:10.1016/j.brainres.2009.09.074 · Cited by 465
Graphical analysis of PET data applied to reversible and irreversible tracers
Logan, J. (2000) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(00)00137-2 · Cited by 416
Yang, H., de Jong, J. W., Tak, Y., Peck, J., Bateup, H. S., & Lammel, S. (2018) · Neuron · doi:10.1016/j.neuron.2017.12.022 · Cited by 407
Castro, D. C., & Berridge, K. C. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.4458-13.2014 · Cited by 395
Structure of the Nanobody-Stabilized Active State of the Kappa Opioid Receptor
Che, T., Majumdar, S., Zaidi, S. A., Ondachi, P. W., McCorvy, J. D., Wang, S., Mosier, P. D., Uprety, R., Vardy, E., Krumm, B. E., et al. (2018) · Cell · doi:10.1016/j.cell.2017.12.011 · Cited by 386
Baldo, B. A., Daniel, R. A., Berridge, C. W., & Kelley, A. E. (2003) · The Journal of Comparative Neurology · doi:10.1002/cne.10783 · Cited by 346
Distinct subpopulations of nucleus accumbens dynorphin neurons drive aversion and reward
Al-Hasani, R., McCall, J. G., Shin, G., Gomez, A. M., Schmitz, G. P., Bernardi, J. M., Pyo, C.-O., Park, S. I., Marcinkiewcz, C. M., Crowley, N. A., et al. (2015) · Neuron · doi:10.1016/j.neuron.2015.08.019 · Cited by 345
Self-citationCommon brain mechanisms of chronic pain and addiction
Elman, I., & Borsook, D. (2016) · Neuron · doi:10.1016/j.neuron.2015.11.027 · Cited by 303
Land, B. B., Bruchas, M. R., Schattauer, S., Giardino, W. J., Aita, M., Messinger, D., Hnasko, T. S., Palmiter, R. D., & Chavkin, C. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910705106 · Cited by 301
Self-citationDecreased motivation during chronic pain requires long-term depression in the nucleus accumbens
Schwartz, N., Temkin, P., Jurado, S., Lim, B. K., Heifets, B. D., Polepalli, J. S., & Malenka, R. C. (2014) · Science · doi:10.1126/science.1253994 · Cited by 278
κ-Opioid Agonists Directly Inhibit Midbrain Dopaminergic Neurons
Margolis, E. B., Hjelmstad, G. O., Bonci, A., & Fields, H. L. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-31-09981.2003 · Cited by 276
Pain and suicidality: Insights from reward and addiction neuroscience
Elman, I., Borsook, D., & Volkow, N. D. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.06.003 · Cited by 226
Bruchas, M. R., Land, B. B., Lemos, J. C., & Chavkin, C. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008528 · Cited by 209
Self-citationThe indirect pathway of the nucleus accumbens shell amplifies neuropathic pain
Ren, W., Centeno, M. V., Berger, S., Wu, Y., Na, X., Liu, X., Kondapalli, J., Apkarian, A. V., Martina, M., & Surmeier, D. J. (2015) · Nature Neuroscience · doi:10.1038/nn.4199 · Cited by 208
Executive Function and Decision-Making in Women with Fibromyalgia
Verdejo‐García, A., López-Torrecillas, F., Calandre, E. P., Delgado-Rodriguez, A., & Bechara, A. (2009) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/acp014 · Cited by 182
Dynorphin Controls the Gain of an Amygdalar Anxiety Circuit
Crowley, N. A., Bloodgood, D. W., Hardaway, J. A., Kendra, A. M., McCall, J. G., Al‐Hasani, R., McCall, N. M., Yu, W., Schools, Z. L., Krashes, M. J., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.02.069 · Cited by 149
Self-citationSpatiotemporal Control of Opioid Signaling and Behavior
Siuda, E. R., Copits, B. A., Schmidt, M. J., Baird, M. A., Al‐Hasani, R., Planer, W., Funderburk, S. C., McCall, J. G., Gereau, R. W., & Bruchas, M. R. (2015) · Neuron · doi:10.1016/j.neuron.2015.03.066 · Cited by 146
Self-citationThe one-two punch of alcoholism: role of central amygdala dynorphins/kappa-opioid receptors
Kissler, J. L., Sirohi, S., Reis, D. J., Jansen, H. T., Quock, R. M., Smith, D. G., & Walker, B. M. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.03.014 · Cited by 145
Self-citationTejeda, H. A., Wu, J., Kornspun, A. R., Pignatelli, M., Kashtelyan, V., Krashes, M. J., Lowell, B. B., Carlezon, W. A., & Bonci, A. (2017) · Neuron · doi:10.1016/j.neuron.2016.12.005 · Cited by 141
The Therapeutic Potential of κ-Opioids for Treatment of Pain and Addiction
Chavkin, C. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.137 · Cited by 133
Kappa opioid receptor signaling in the brain: Circuitry and implications for treatment
Crowley, N. A., & Kash, T. L. (2015) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.01.001 · Cited by 131
Narita, M., Kishimoto, Y., Ise, Y., Yajima, Y., Misawa, K., & Suzuki, T. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300527 · Cited by 128
Reward‐aversion circuitry in analgesia and pain: Implications for psychiatric disorders
Borsook, D., Becerra, L. R., Carlezon, W. A., Shaw, M. E., Renshaw, P. F., Elman, I., & Levine, J. D. (2006) · European Journal of Pain · doi:10.1016/j.ejpain.2005.12.005 · Cited by 124
Heroin self-administration in rats under a progressive ratio schedule of reinforcement
Roberts, D. C. S., & Bennett, S. A. L. (1993) · Psychopharmacology · doi:10.1007/bf02245526 · Cited by 123
Hipólito, L., Wilson‐Poe, A. R., Campos‐Jurado, Y., Zhong, E., González-Romero, J. L., Virag, L., Whittington, R. A., Comer, S. D., Carlton, S. M., Walker, B. M., et al. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.1053-15.2015 · Cited by 114
Self-citationPhotoactivatable Neuropeptides for Spatiotemporally Precise Delivery of Opioids in Neural Tissue
Banghart, M. R., & Sabatini, B. L. (2012) · Neuron · doi:10.1016/j.neuron.2011.11.016 · Cited by 100
Zheng, M., Nabulsi, N., Kim, S., Tomasi, G., Lin, S.-F., Mitch, C. H., Quimby, S. J., Barth, V., Rash, K. S., Masters, J. J., et al. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.112.109512 · Cited by 90
Leitl, M. D., Onvani, S., Bowers, M. S., Cheng, K., Rice, K. C., Carlezon, W. A., Banks, M. L., & Negus, S. S. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2013.236 · Cited by 87
Roles of Nucleus Accumbens CREB and Dynorphin in Dysregulation of MotivationPreprint
Muschamp, J. W., & Carlezon, W. A. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a012005 · Cited by 74
Shippenberg, T. S., Stein, C., Huber, A., Millan, M. J., & Herz, A. (1988) · Pain · doi:10.1016/0304-3959(88)90225-4 · Cited by 71
Hybrid image and blood sampling input function for quantification of small animal dynamic PET data
Shoghi, K. I., & Welch, M. J. (2007) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2007.07.010 · Cited by 40
Self-citationHedonic and motivational responses to food reward are unchanged in rats with neuropathic pain
Okun, A., McKinzie, D. L., Witkin, J. M., Remeniuk, B., Husein, O. F., Gleason, S. D., Oyarzo, J. N., Navratilova, E., McElroy, B., Cowen, S. L., et al. (2016) · Pain · doi:10.1097/j.pain.0000000000000695 · Cited by 37
Kappa Antagonist JDTic in Phase 1 Clinical Trial
Chavkin, C., & Martínez, D. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.74 · Cited by 29
Neuropathic Pain Alters Reward and Affect via Kappa Opioid Receptor (KOR) Upregulation
Liu, S., Cook, C. P., Thai, E., Pickens, S. R., Taylor, A. M., Tea, V. D., Carroll, F. I., Leslie, F. M., Evans, C. J., & Cahill, C. M. (2016) · The FASEB Journal · doi:10.1096/fasebj.30.1_supplement.928.5 · Cited by 5
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Neurobiology of opioid addiction: Opponent process, hyperkatifeia, and negative reinforcement
Koob, G. F. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2019.05.023 · Cited by 477
Cellular Circuits in the Brain and Their Modulation in Acute and Chronic Pain
Kuner, R., & Kuner, T. (2020) · Physiological Reviews · doi:10.1152/physrev.00040.2019 · Cited by 371
Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development
Koob, G. F. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000083 · Cited by 337
Castro, D. C., & Bruchas, M. R. (2019) · Neuron · doi:10.1016/j.neuron.2019.03.003 · Cited by 306
Self-citationBrain circuits for pain and its treatment
Lindsay, N. M., Chen, C., Gilam, G., Mackey, S., & Scherrer, G. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abj7360 · Cited by 246
Metadata
- Authors
- Massaly, N., Copits, B. A., Wilson-Poe, A. R., Hipólito, L., Markovic, T., Yoon, H. J., Liu, S., Walicki, M. C., Bhatti, D. L., Sirohi, S., Klaas, A., Walker, B. M., Neve, R., Cahill, C. M., Shoghi, K. I., Gereau, R. W., McCall, J. G., Al-Hasani, R., Bruchas, M. R., & Morón, J. A.
- Affiliations
- Washington University in St. Louis (US)
- University of California, Los Angeles (US)
- University of Health Sciences and Pharmacy (US)
- Washington State University (US)
- Massachusetts Institute of Technology (US)
- Corresponding author
- Bruchas, Michael R.
- ORCID
- Venue
- Neuron
- Publisher
- Elsevier BV
- Published
- 2019-05
- Volume
- 102
- Issue
- 3
- Pages
- 564-573.e6
- ISSN
- 0896-6273 (ISSN-L)
- PMC
- PMC6509001
- OpenAlex
- W2922000881
- Cited by
- 200
- References
- 45
- Citations by year
- 2026: 19 · 2025: 28 · 2024: 21 · 2023: 16 · 2022: 27 · 2021: 49 · 2020: 28 · 2019: 12
- FWCI
- 13.85
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Neuron (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Institutes of Health (DA041781, DA042581, DA042499, DA041883, DA045463)
- Brain and Behavior Research Foundation (DA033396, DA037152, R01-NS106953, AA020394, K99/R00-DA038725, K99-DA041467)
- Philippe Foundation
- Mallinckrodt Institute of Radiology at Washington University (16-014)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- nucleus accumbens shell, kappa opioid receptor, opioid overdose, aversive behavior, reward processing
- MeSH terms
- Affect, Animals, Dynorphins, Inflammation, Neural Inhibition, Neuronal Plasticity, Neurons, Nucleus Accumbens, Pain, Receptors, Opioid, kappa, Mood Disorders, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
